Skip to main content
. 2021 Dec 30;100(52):e28407. doi: 10.1097/MD.0000000000028407

Figure 1.

Figure 1

Image of a 49-year-old woman with BCLM who showed a partial response after DEB-TACE treatment. A, D: Portal phase image of contrast-enhanced CT showed low-attenuated lesions (red arrow): B, E: At 3-months follow-up CT, the metastasis lesions decreased: C, F: At 6-months follow-up CT, the liver metastases decreased significantly. BCLM = breast cancer liver metastases, CT = computed tomography, DEB-TACE = drug-eluting beads used for transarterial-chemoembolization.